Fibronectin in human bile fluid for diagnosis of malignant biliary diseases

Hepatology

Volumn 23, Issue 3, 1996, Pages 423-428

  Körner, Thomas ^a,c   Kropf, Jürgen ^b   Hackler, Rolf ^b   Brenzel, Arnfried ^b   Gressner, Axel M ^b  

^a Suhl Central Hospital   (Germany)

^b PHILIPPS UNIVERSITY MARBURG   (Germany)

^c Klinikum Suhl   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

FIBRONECTIN;

ADULT; AGED; ARTICLE; BILE DUCT CANCER; BILE DUCT OBSTRUCTION; BILE LEVEL; BILIARY TRACT DISEASE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; DIFFERENTIAL DIAGNOSIS; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; REFERENCE VALUE;

EID: 0029942394     PISSN: 02709139     EISSN: None     Source Type: Journal    
DOI: 10.1002/hep.510230305     Document Type: Article

References (26)

1. Ruoslahti E. Fibronectin and its receptors. Annu Rev Biochem 1988;57:375.
2. Tamkun JW, Hynes RO. Plasma fibronectin is synthesized and secreted by hepatocytes. J Biol Chem 1983;258:4641-4647.
3. Malmström P-U, Larsson A, Johansson S. Urinary fibronectin in diagnosis and follow-up of patients with urinary bladder cancer. Br J Urol 1993;72:307-310.
4. Paizi M, Manaster J, Quitt M, Spira G. High plasma fibronectin levels in multiple myeloma patients: possible mechanism and clinical implications. Scand J Immunol 1991;34:285-289.
5. Schölmerich J, Volk BA, Köttgen E, Ehlers S, Gerok W. Fibronectin concentration in ascites differentiates between malignant and nonmalignant ascites. Gastroenterology 1984;87:1160-1164.
6. Salmayenli N, Sivas A. Significance of fibronectin in cirrhotic and malignant ascites. J Clin Biochem Nutr 1990;9:191-196.
7. Cilli A, Buccino G, Cocciolo M, Parravicini R, Mariani F, Scaltrini G. Diagnostic accuracy of fibronectin in the differential diagnosis of ascites. Cancer 1986;58:2489-2493.
8. Körner Th, Kropf J, Gressner AM. Fibronectingehalt der Galle. Dtsch Med Wochenschr 1993;118:646.
9. Körner Th, Kropf J, Jaspersen D, Schorr W, Hammar CH, Gressner AM. Fibronectin in menschlicher Galle: Ein neuer Parameter zur Diagnostik maligner Gallengangsprozesse? Eine Pilotstudie. Z Gastroentrol 1994;32:87-90.
10. Kropf J, Quitte E, Gressner AM. Time resolved immuno-fluorometric assays with measurement of a europium chelate in solution: application for sensitive determination of fibronectin. Anal Biochem 1991;197:258-265.
11. Vartio T, Laitinen L, Narvanen O, Cutoto M, Thornell LE, Zardi L, Virtanen I. Differential expression of the ED sequence-containing form of cellular fibronectin in embryonic and adult human tissues. J Cell Sci 1987;88:419-430.
12. Greiling H, Gressner AM, eds. Lehrbuch der Klinischen Chemie und Pathobiochemie, 3. Auflage, Schattauer-Verlag, 1995.
13. Ruoslahti E, Hayman EG, Pierschbacher M, Engvall E. Fibronectin: purification, immunochemical properties, and biological activities. Methods Enzymol 1982;82:803.
14. Twining SS. Fuorescein isothiocyanate-labeled casein assay for proteolytic enzymes. Anal Biochem 1984;143:30-34.
15. Laemmli UK. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 1970;227:680-685.
16. Geerts A, Geuze HJ, Slot JW, Voss B, Schuppan D, Schellinck P, Wiese E. Immuno localization of procollagen III, fibronectin and heparan sulfate proteoglycan on ultrathin frozen sections of the normal rat liver. Histochemistry 1986;84:355-362.
17. Baranov V, Rescan PY, Rissel M, Grimaud JA, Guillouzo A. Ultrastructural localization of the major components of the extracellular matrix in normal mouse liver. J Submicrosc Cytol Pathol 1990;22:497-506.
18. Chijiiwa K, Koga A, Yamasaki T, Shimada K, Noshiro H, Nakayama F. Fibronectin: a possible factor promoting cholesterol monohydrate crystallization in bile. Biochim Biophys Acta 1991;1086:48.
19. Juvonen T, Kairaluoma MI, Malinen H, Niemelä O. Extracellular matrix proteins in bile and serum of patients with gallstone disease. Connect Tissue Res 1993;29:171-181.
20. Hynes RO. Fibronectins. Berlin-Heidelberg-New York: Springer, 1990:300-334.
21. Szendroi M, Lapis K. Distribution of fibronectin and laminin in human liver tumors. J Cancer Res Clin Oncol 1984;109:64.
22. Stamatoglou SC, Manson MM, Green JA, Mayol X, Hughes RC. Distribution of fibronectin and fibronectin-binding proteins, AGp110 and integrin alpha 5 beta 11, during chemically induced hepatocarcinogenesis in adult rats. J Cell Sci 1991;100:599-604.
23. Szendroi M, Lapis K, Zalatnai A, Robert L, Labat-Robert J. Appearance of fibronectin in putative preneoplastic lesions and in hepatocellular carcinoma during chemical hepatocarcino-geneses in rats and in human hepatomas. J Exp Pathol 1984;1:189-199.
24. Ker CG, Chen JS, Lee KT, Sheen PC, Wu CC. Assessment of serum and bile levels of CA 19-9 and CA 125 in cholangitis and bile duct carcinoma. J Gastroenterol Hepatol 1991;6:505-508.
25. Arias IM, Che M, Gatmaitan Z, Leveille C, Nishida T, Pierre MS. The biology of the bile canaliculus. HEPATOLOGY 1993;17: 318-329.
26. Gressner AM, Wallraff P. The use of laser nephelometry for the determination and computer-assisted calculation of the fibronectin concentration in various body fluids. J Clin Chem Clin Biochem 1980;18:797-805.